"Plasmablastic Lymphoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Malignant lymphoma composed of large B lymphoid cells which have the immunophenotype of plasma cells and a predilection for the ORAL CAVITY.
| Descriptor ID |
D000069293
|
| MeSH Number(s) |
C04.557.386.480.150.585.500 C15.604.515.569.480.150.585.500 C20.683.515.761.480.150.585.500
|
| Concept/Terms |
Plasmablastic Lymphoma- Plasmablastic Lymphoma
- Lymphoma, Plasmablastic
- Lymphomas, Plasmablastic
- Plasmablastic Lymphomas
- Plasmablasts Diffuse Large B-cell Lymphoma
- Plasmablasts Diffuse Large B cell Lymphoma
- Plasmablastic Diffuse Large B-cell Lymphoma
- Plasmablastic Diffuse Large B cell Lymphoma
|
Below are MeSH descriptors whose meaning is more general than "Plasmablastic Lymphoma".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Lymphoma [C04.557.386]
- Lymphoma, Non-Hodgkin [C04.557.386.480]
- Lymphoma, B-Cell [C04.557.386.480.150]
- Lymphoma, Large B-Cell, Diffuse [C04.557.386.480.150.585]
- Plasmablastic Lymphoma [C04.557.386.480.150.585.500]
- Hemic and Lymphatic Diseases [C15]
- Lymphatic Diseases [C15.604]
- Lymphoproliferative Disorders [C15.604.515]
- Lymphoma [C15.604.515.569]
- Lymphoma, Non-Hodgkin [C15.604.515.569.480]
- Lymphoma, B-Cell [C15.604.515.569.480.150]
- Lymphoma, Large B-Cell, Diffuse [C15.604.515.569.480.150.585]
- Plasmablastic Lymphoma [C15.604.515.569.480.150.585.500]
- Immune System Diseases [C20]
- Immunoproliferative Disorders [C20.683]
- Lymphoproliferative Disorders [C20.683.515]
- Lymphoma [C20.683.515.761]
- Lymphoma, Non-Hodgkin [C20.683.515.761.480]
- Lymphoma, B-Cell [C20.683.515.761.480.150]
- Lymphoma, Large B-Cell, Diffuse [C20.683.515.761.480.150.585]
- Plasmablastic Lymphoma [C20.683.515.761.480.150.585.500]
Below are MeSH descriptors whose meaning is more specific than "Plasmablastic Lymphoma".
This graph shows the total number of publications written about "Plasmablastic Lymphoma" by people in this website by year, and whether "Plasmablastic Lymphoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 2 | 0 | 2 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Plasmablastic Lymphoma" by people in Profiles.
-
Managing the front-line treatment for diffuse large B cell lymphoma and high-grade B cell lymphoma during the COVID-19 outbreak. Br J Haematol. 2020 11; 191(3):386-389.
-
Plasmablastic lymphoma of bone marrow: Report of a rare case and immunohistochemistry based approach to the diagnosis. Indian J Pathol Microbiol. 2019 Jan-Mar; 62(1):107-110.
-
Clinicopathological analysis of oral plasmablastic lymphoma: A systematic review. J Oral Pathol Med. 2018 Nov; 47(10):915-922.
-
First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature. Front Immunol. 2018; 9:113.
-
Interleukin-6-dependent growth in a newly established plasmablastic lymphoma cell line and its therapeutic targets. Sci Rep. 2017 08 31; 7(1):10188.
-
IgA plasmablastic large B-cell lymphoma. Diagnosis (Berl). 2017 06 27; 4(2):105-107.